The report covers forecast and analysis for the non-invasive prenatal testing (NIPT) market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the non-invasive prenatal testing (NIPT) market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the non-invasive prenatal testing (NIPT) market on a global level.


In order to give the users of this report a comprehensive view on the non-invasive prenatal testing (NIPT) market, we have included competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein test type segment and end-user segment are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.


The study provides a decisive view on the non-invasive prenatal testing (NIPT) market by segmenting the market based on test type, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022. Based on test type the market is segmented into panel 1, panel 2 and panel 3. Key end-users covered under this study include hospitals, diagnostic centers, and maternity clinics. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and Middle East Africa with its further bifurcation into major countries including the U.S., Canada, Rest of North America, Germany, U.K., France, Italy, Spain, Russia, Rest of Europe, China, Japan, India, Australia, Rest of Asia Pacific, Brazil, Mexico, Argentina, Rest of Latin America, Saudi Arabia, UAE, Qatar, South Africa and Rest of Middle East and Africa. This segmentation includes demand for veterinary anti-infectives based on individual test type and end-users in all the regions and countries.


The report also includes detailed profiles of end players such Ariosa Diagnostics, Inc., Berry Genomics Co., Ltd, BGI Diagnostics, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom Laboratories, and Quest Diagnostics, Inc.


This report segments the global non-invasive prenatal testing (NIPT) market as follows:


Global Non-Invasive Prenatal Testing (NIPT) Market: Test Type Segment Analysis

Panel 1

Panel 2

Panel 3

Global Non-Invasive Prenatal Testing (NIPT) Market: End-user Segment Analysis

Hospitals

Diagnostic Centers

Maternity Clinics

Global Non-Invasive Prenatal Testing (NIPT) Market: Regional Segment Analysis

North America


U.S.

Europe


UK

France

Germany

Asia Pacific


China

Japan

India

Latin America


Brazil

Middle East and Africa